221 related articles for article (PubMed ID: 11434888)
61. Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Bellettato CM; Pinamonti S; Degitz K; Holgate ST; Johnston SL
FASEB J; 2002 Dec; 16(14):1934-6. PubMed ID: 12368227
[TBL] [Abstract][Full Text] [Related]
62. An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.
Traub S; Nikonova A; Carruthers A; Dunmore R; Vousden KA; Gogsadze L; Hao W; Zhu Q; Bernard K; Zhu J; Dymond M; McLean GR; Walton RP; Glanville N; Humbles A; Khaitov M; Wells T; Kolbeck R; Leishman AJ; Sleeman MA; Bartlett NW; Johnston SL
PLoS Pathog; 2013; 9(8):e1003520. PubMed ID: 23935498
[TBL] [Abstract][Full Text] [Related]
63. Host immune responses to rhinovirus: mechanisms in asthma.
Kelly JT; Busse WW
J Allergy Clin Immunol; 2008 Oct; 122(4):671-682. PubMed ID: 19014757
[TBL] [Abstract][Full Text] [Related]
64. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
65. Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood.
Custovic A; Belgrave D; Lin L; Bakhsoliani E; Telcian AG; Solari R; Murray CS; Walton RP; Curtin J; Edwards MR; Simpson A; Rattray M; Johnston SL
Am J Respir Crit Care Med; 2018 May; 197(10):1265-1274. PubMed ID: 29466680
[TBL] [Abstract][Full Text] [Related]
66. Human bocavirus 1 may suppress rhinovirus-associated immune response in wheezing children.
Lukkarinen H; Söderlund-Venermo M; Vuorinen T; Allander T; Hedman K; Simell O; Ruuskanen O; Jartti T
J Allergy Clin Immunol; 2014 Jan; 133(1):256-8.e1-4. PubMed ID: 24369801
[No Abstract] [Full Text] [Related]
67. An update on the pathophysiology of rhinovirus upper respiratory tract infections.
van Kempen M; Bachert C; Van Cauwenberge P
Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986
[TBL] [Abstract][Full Text] [Related]
68. Rhinovirus-induced asthma exacerbations and risk populations.
Coleman L; Laing IA; Bosco A
Curr Opin Allergy Clin Immunol; 2016 Apr; 16(2):179-85. PubMed ID: 26836624
[TBL] [Abstract][Full Text] [Related]
69. The role of ICAM-1 on T-cells in the pathogenesis of asthma.
Stanciu LA; Djukanovic R
Eur Respir J; 1998 Apr; 11(4):949-57. PubMed ID: 9623703
[TBL] [Abstract][Full Text] [Related]
70. The role of chemokines in virus-associated asthma exacerbations.
Kallal LE; Lukacs NW
Curr Allergy Asthma Rep; 2008 Sep; 8(5):443-50. PubMed ID: 18682112
[TBL] [Abstract][Full Text] [Related]
71. Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.
Silkoff PE; Flavin S; Gordon R; Loza MJ; Sterk PJ; Lutter R; Diamant Z; Turner RB; Lipworth BJ; Proud D; Singh D; Eich A; Backer V; Gern JE; Herzmann C; Halperin SA; Mensinga TT; Del Vecchio AM; Branigan P; San Mateo L; Baribaud F; Barnathan ES; Johnston SL
J Allergy Clin Immunol; 2018 Apr; 141(4):1220-1230. PubMed ID: 28734844
[TBL] [Abstract][Full Text] [Related]
72. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.
Zambrano JC; Carper HT; Rakes GP; Patrie J; Murphy DD; Platts-Mills TA; Hayden FG; Gwaltney JM; Hatley TK; Owens AM; Heymann PW
J Allergy Clin Immunol; 2003 May; 111(5):1008-16. PubMed ID: 12743565
[TBL] [Abstract][Full Text] [Related]
73. Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
Matsuse H; Kondo Y; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Mizuta Y; Kohno S
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):55-60. PubMed ID: 16892782
[TBL] [Abstract][Full Text] [Related]
74. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells.
Edwards MR; Hewson CA; Laza-Stanca V; Lau HT; Mukaida N; Hershenson MB; Johnston SL
Mol Immunol; 2007 Mar; 44(7):1587-97. PubMed ID: 16989899
[TBL] [Abstract][Full Text] [Related]
75. Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells.
Greiller CL; Suri R; Jolliffe DA; Kebadze T; Hirsman AG; Griffiths CJ; Johnston SL; Martineau AR
J Steroid Biochem Mol Biol; 2019 Mar; 187():152-159. PubMed ID: 30476590
[TBL] [Abstract][Full Text] [Related]
76. The relationship of viral respiratory infections and asthma.
Busse WW; Lemanske RF; Dick EC
Chest; 1992 Jun; 101(6 Suppl):385S-388S. PubMed ID: 1591936
[No Abstract] [Full Text] [Related]
77. Viral infections in asthma and COPD.
Matsumoto K; Inoue H
Respir Investig; 2014 Mar; 52(2):92-100. PubMed ID: 24636264
[TBL] [Abstract][Full Text] [Related]
78. Altered mast cell activity in response to rhinovirus infection provides novel insight into asthma.
Liu H; Tan J; Liu J; Feng H; Pan D
J Asthma; 2020 May; 57(5):459-467. PubMed ID: 30882256
[No Abstract] [Full Text] [Related]
79. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure?
de Kluijver J; Evertse CE; Sont JK; Schrumpf JA; van Zeijl-van der Ham CJ; Dick CR; Rabe KF; Hiemstra PS; Sterk PJ
Am J Respir Crit Care Med; 2003 Nov; 168(10):1174-80. PubMed ID: 12893645
[TBL] [Abstract][Full Text] [Related]
80. [Viral infections and asthma].
Gourdon C; Pauli G
Presse Med; 1993 Mar; 22(10):480-6. PubMed ID: 8511069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
